Cryo-Rop Headquarters - Phase III

Palmer, Earl A.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Eye Institute (NEI)
• Type: Cooperative Clinical Research--Cooperative Agreements (U10)
• Project #: 5U10EY005874-12
• Application #: 2159629
• Study Section: Vision Research and Training Committee (VSN)
• Project Start: 1990-06-01
• Project End: 1999-05-31
• Budget Start: 1996-06-01
• Budget End: 1997-05-31
• Support Year: 12
• Fiscal Year: 1996

Institution

• Name: Oregon Health and Science University
• Department: Ophthalmology
• Type: Schools of Medicine
• DUNS #: 009584210
• City: Portland
• State: OR
• Country: United States
• Zip Code: 97239

Publications

Siatkowski, R Michael; Dobson, Velma; Quinn, Graham E et al. (2007) Severe visual impairment in children with mild or moderate retinal residua following regressed threshold retinopathy of prematurity. J AAPOS 11:148-152

Dobson, Velma; Quinn, Graham E; Summers, C Gail et al. (2006) Visual acuity at 10 years in Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) study eyes: effect of retinal residua of retinopathy of prematurity. Arch Ophthalmol 124:199-202

Quinn, Graham E; Dobson, Velma; Saigal, Saroj et al. (2004) Health-related quality of life at age 10 years in very low-birth-weight children with and without threshold retinopathy of prematurity. Arch Ophthalmol 122:1659-66

Hardy, Robert J; Palmer, Earl A; Dobson, Velma et al. (2003) Risk analysis of prethreshold retinopathy of prematurity. Arch Ophthalmol 121:1697-701

Palmer, Earl A (2003) Implications of the natural course of retinopathy of prematurity. Pediatrics 111:885-6

Reynolds, James D; Dobson, Velma; Quinn, Graham E et al. (2002) Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies. Arch Ophthalmol 120:1470-6

Cryotherapy for Retinopathy of Prematurity Cooperative Group (2001) Effect of retinal ablative therapy for threshold retinopathy of prematurity: results of Goldmann perimetry at the age of 10 years. Arch Ophthalmol 119:1120-5

Cryotherapy for Retinopathy of Prematurity Cooperative Group (2001) Contrast sensitivity at age 10 years in children who had threshold retinopathy of prematurity. Arch Ophthalmol 119:1129-33

Repka, M X; Palmer, E A; Tung, B (2000) Involution of retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol 118:645-9

Dobson, V; Quinn, G E; Siatkowski, R M et al. (1999) Agreement between grating acuity at age 1 year and Snellen acuity at age 5.5 years in the preterm child. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Invest Ophthalmol Vis Sci 40:496-503